Followers

9
9
4
4
.
2
2
4
4
0.32 (0.76%)

As on 07 Jan, 2026 | 16:01

Open Trading A/c
Day Range
40.11
44.24
LH
52 Week Range
26.69
48.16
LH
Volume
* i
Bid / Ask
2,773.00
0.00 / 0.00

Bacil Pharma Announcements

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Khem Sum Apparels Overseas Ltd

30 Dec, 2025 | 05:34pm • Source: BSE

Closure of Trading Window

29 Dec, 2025 | 07:20pm • Source: BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Suman P Shah

29 Dec, 2025 | 12:50pm • Source: BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gulecha Investment & Trading Co...

29 Dec, 2025 | 12:48pm • Source: BSE

Appointment of Whole Time Company Secretary

19 Dec, 2025 | 06:39pm • Source: BSE

Resignation of Wholetime Company Secretary

01 Dec, 2025 | 06:25pm • Source: BSE

Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and...

05 Nov, 2025 | 01:20pm • Source: BSE

Compliance Certificate under Reg.74(5)

14 Oct, 2025 | 05:34pm • Source: BSE

Scrutinizer Report of Shareholders Meeting of the company held on 29th September 2025

30 Sep, 2025 | 03:52pm • Source: BSE

Proceeding of 38th Annual General Meeting of the Company held on September 29, 2025

29 Sep, 2025 | 01:49pm • Source: BSE

Book Closure for the Purpose of Annual General Meeting

05 Sep, 2025 | 02:55pm • Source: BSE

38th Annual Report of the Company

05 Sep, 2025 | 02:51pm • Source: BSE

Notice of 38th Annual General Meeting of the Company

05 Sep, 2025 | 02:45pm • Source: BSE

Outcome of Board Meeting held on 05th September, 2025

05 Sep, 2025 | 02:40pm • Source: BSE

Intimation of Receipt of Request for Reclassifiaction of the Promoter in accordance with Regulation 31A of the Securities and Exchange Board of India (Listing Obligations...

04 Sep, 2025 | 09:01pm • Source: BSE

Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2025 ,inter alia, to consider and...

02 Sep, 2025 | 02:09pm • Source: BSE

Revised outcome of Board Meeting held on 25th August 2025. The earlier revised outcome uploaded has incorrect w.e.f date of appointment of statutory auditor. The...

27 Aug, 2025 | 03:02pm • Source: BSE

Approval for Appointment of M/s Sarang Shivajirao Chavan & Associates as the Statutory Auditor of the Company.

27 Aug, 2025 | 02:52pm • Source: BSE

Revised outcome of Board Meeting on 25th August 2025

27 Aug, 2025 | 02:44pm • Source: BSE

Announcement under Regulation 30 (LODR) - Appointment of Statutory Auditor M/s Sarang Shivajirao Chavan & Associates

25 Aug, 2025 | 06:58pm • Source: BSE